JSPR
Price
$4.88
Change
+$0.33 (+7.24%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
65.65M
UBX
Price
$1.00
Change
+$0.01 (+1.01%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
16.56M
Ad is loading...

JSPR vs UBX

Header iconJSPR vs UBX Comparison
Open Charts JSPR vs UBXBanner chart's image
Jasper Therapeutics
Price$4.88
Change+$0.33 (+7.24%)
Volume$1.26K
Capitalization65.65M
Unity Biotechnology
Price$1.00
Change+$0.01 (+1.01%)
Volume$100
Capitalization16.56M
JSPR vs UBX Comparison Chart
Loading...
JSPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
JSPR vs. UBX commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JSPR is a Buy and UBX is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (JSPR: $4.55 vs. UBX: $0.99)
Brand notoriety: JSPR and UBX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: JSPR: 115% vs. UBX: 45%
Market capitalization -- JSPR: $65.65M vs. UBX: $16.56M
JSPR [@Biotechnology] is valued at $65.65M. UBX’s [@Biotechnology] market capitalization is $16.56M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

JSPR’s FA Score shows that 2 FA rating(s) are green whileUBX’s FA Score has 0 green FA rating(s).

  • JSPR’s FA Score: 2 green, 3 red.
  • UBX’s FA Score: 0 green, 5 red.
According to our system of comparison, JSPR is a better buy in the long-term than UBX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

JSPR’s TA Score shows that 5 TA indicator(s) are bullish while UBX’s TA Score has 6 bullish TA indicator(s).

  • JSPR’s TA Score: 5 bullish, 3 bearish.
  • UBX’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, UBX is a better buy in the short-term than JSPR.

Price Growth

JSPR (@Biotechnology) experienced а +16.07% price change this week, while UBX (@Biotechnology) price change was +3.68% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.94%. For the same industry, the average monthly price growth was -5.37%, and the average quarterly price growth was -12.15%.

Reported Earning Dates

JSPR is expected to report earnings on Feb 28, 2025.

UBX is expected to report earnings on May 09, 2023.

Industries' Descriptions

@Biotechnology (+7.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JSPR($65.6M) has a higher market cap than UBX($16.6M). UBX YTD gains are higher at: 1.086 vs. JSPR (-78.718). UBX has higher annual earnings (EBITDA): -25.12M vs. JSPR (-74.87M). JSPR has more cash in the bank: 71.6M vs. UBX (23.2M). JSPR has less debt than UBX: JSPR (1.81M) vs UBX (23.5M). JSPR (0) and UBX (0) have equivalent revenues.
JSPRUBXJSPR / UBX
Capitalization65.6M16.6M395%
EBITDA-74.87M-25.12M298%
Gain YTD-78.7181.086-7,251%
P/E RatioN/AN/A-
Revenue00-
Total Cash71.6M23.2M309%
Total Debt1.81M23.5M8%
FUNDAMENTALS RATINGS
UBX: Fundamental Ratings
UBX
OUTLOOK RATING
1..100
1
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
94
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
JSPRUBX
RSI
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
76%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
64%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bullish Trend 2 days ago
59%
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bullish Trend 2 days ago
64%
Bullish Trend 2 days ago
68%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
63%
Bullish Trend 2 days ago
75%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 4 days ago
71%
Bullish Trend 2 days ago
76%
Declines
ODDS (%)
Bearish Trend 17 days ago
82%
Bearish Trend 21 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
75%
Aroon
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Ad is loading...
JSPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KIND1.450.04
+2.84%
Nextdoor Holdings
BIVI0.840.02
+2.48%
BioVie Inc
CPAY314.576.80
+2.21%
Corpay
SLG53.550.55
+1.04%
SL Green Realty Corp
TSQ6.80-0.05
-0.73%
Townsquare Media

JSPR and

Correlation & Price change

A.I.dvisor indicates that over the last year, JSPR has been loosely correlated with AUPH. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if JSPR jumps, then AUPH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JSPR
1D Price
Change %
JSPR100%
+4.12%
AUPH - JSPR
44%
Loosely correlated
+2.41%
ATNF - JSPR
38%
Loosely correlated
-2.16%
AVXL - JSPR
38%
Loosely correlated
+0.87%
MNMD - JSPR
36%
Loosely correlated
+5.00%
ABCL - JSPR
35%
Loosely correlated
+0.79%
More

UBX and

Correlation & Price change

A.I.dvisor indicates that over the last year, UBX has been loosely correlated with NCNA. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if UBX jumps, then NCNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UBX
1D Price
Change %
UBX100%
+0.51%
NCNA - UBX
42%
Loosely correlated
+14.09%
JSPR - UBX
33%
Loosely correlated
+4.12%
ASMB - UBX
33%
Poorly correlated
+3.38%
ORMP - UBX
33%
Poorly correlated
+0.66%
MNMD - UBX
32%
Poorly correlated
+5.00%
More